197 related articles for article (PubMed ID: 30563940)
1. LCAT Enzyme Replacement Therapy Reduces LpX and Improves Kidney Function in a Mouse Model of Familial LCAT Deficiency.
Vaisman BL; Neufeld EB; Freeman LA; Gordon SM; Sampson ML; Pryor M; Hillman E; Axley MJ; Karathanasis SK; Remaley AT
J Pharmacol Exp Ther; 2019 Mar; 368(3):423-434. PubMed ID: 30563940
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein X Causes Renal Disease in LCAT Deficiency.
Ossoli A; Neufeld EB; Thacker SG; Vaisman B; Pryor M; Freeman LA; Brantner CA; Baranova I; Francone NO; Demosky SJ; Vitali C; Locatelli M; Abbate M; Zoja C; Franceschini G; Calabresi L; Remaley AT
PLoS One; 2016; 11(2):e0150083. PubMed ID: 26919698
[TBL] [Abstract][Full Text] [Related]
3. A novel in vivo lecithin-cholesterol acyltransferase (LCAT)-deficient mouse expressing predominantly LpX is associated with spontaneous glomerulopathy.
Zhu X; Herzenberg AM; Eskandarian M; Maguire GF; Scholey JW; Connelly PW; Ng DS
Am J Pathol; 2004 Oct; 165(4):1269-78. PubMed ID: 15466392
[TBL] [Abstract][Full Text] [Related]
4. CER-001 ameliorates lipid profile and kidney disease in a mouse model of familial LCAT deficiency.
Ossoli A; Strazzella A; Rottoli D; Zanchi C; Locatelli M; Zoja C; Simonelli S; Veglia F; Barbaras R; Tupin C; Dasseux JL; Calabresi L
Metabolism; 2021 Mar; 116():154464. PubMed ID: 33309714
[TBL] [Abstract][Full Text] [Related]
5. Familial lecithin:cholesterol acyltransferase deficiency: First-in-human treatment with enzyme replacement.
Shamburek RD; Bakker-Arkema R; Auerbach BJ; Krause BR; Homan R; Amar MJ; Freeman LA; Remaley AT
J Clin Lipidol; 2016; 10(2):356-67. PubMed ID: 27055967
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein subfractions highly associated with renal damage in familial lecithin:cholesterol acyltransferase deficiency.
Kuroda M; Holleboom AG; Stroes ES; Asada S; Aoyagi Y; Kamata K; Yamashita S; Ishibashi S; Saito Y; Bujo H
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1756-62. PubMed ID: 24876348
[TBL] [Abstract][Full Text] [Related]
7. Plasma lipoprotein-X quantification on filipin-stained gels: monitoring recombinant LCAT treatment ex vivo.
Freeman LA; Shamburek RD; Sampson ML; Neufeld EB; Sato M; Karathanasis SK; Remaley AT
J Lipid Res; 2019 May; 60(5):1050-1057. PubMed ID: 30808683
[TBL] [Abstract][Full Text] [Related]
8. The HDL mimetic CER-001 remodels plasma lipoproteins and reduces kidney lipid deposits in inherited lecithin:cholesterol acyltransferase deficiency.
Pavanello C; Turri M; Strazzella A; Tulissi P; Pizzolitto S; De Maglio G; Nappi R; Calabresi L; Boscutti G
J Intern Med; 2022 Mar; 291(3):364-370. PubMed ID: 34761839
[TBL] [Abstract][Full Text] [Related]
9. A review on lecithin:cholesterol acyltransferase deficiency.
Saeedi R; Li M; Frohlich J
Clin Biochem; 2015 May; 48(7-8):472-5. PubMed ID: 25172171
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human LCAT normalizes plasma lipoprotein profile in LCAT deficiency.
Simonelli S; Tinti C; Salvini L; Tinti L; Ossoli A; Vitali C; Sousa V; Orsini G; Nolli ML; Franceschini G; Calabresi L
Biologicals; 2013 Nov; 41(6):446-9. PubMed ID: 24140107
[TBL] [Abstract][Full Text] [Related]
11. Human lecithin:cholesterol acyltransferase deficiency: in vivo kinetics of low-density lipoprotein and lipoprotein-X.
Nishiwaki M; Ikewaki K; Bader G; Nazih H; Hannuksela M; Remaley AT; Shamburek RD; Brewer HB
Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1370-5. PubMed ID: 16543491
[TBL] [Abstract][Full Text] [Related]
12. Lecithin/cholesterol acyltransferase modulates diet-induced hepatic deposition of triglycerides in mice.
Karavia EA; Papachristou DJ; Kotsikogianni I; Triantafyllidou IE; Kypreos KE
J Nutr Biochem; 2013 Mar; 24(3):567-77. PubMed ID: 22819565
[TBL] [Abstract][Full Text] [Related]
13. Effect of recombinant human lecithin cholesterol acyltransferase infusion on lipoprotein metabolism in mice.
Rousset X; Vaisman B; Auerbach B; Krause BR; Homan R; Stonik J; Csako G; Shamburek R; Remaley AT
J Pharmacol Exp Ther; 2010 Oct; 335(1):140-8. PubMed ID: 20605907
[TBL] [Abstract][Full Text] [Related]
14. Compound heterozygosity (G71R/R140H) in the lecithin:cholesterol acyltransferase (LCAT) gene results in an intermediate phenotype between LCAT-deficiency and fish-eye disease.
Hörl G; Kroisel PM; Wagner E; Tiran B; Petek E; Steyrer E
Atherosclerosis; 2006 Jul; 187(1):101-9. PubMed ID: 16216249
[TBL] [Abstract][Full Text] [Related]
15. LCAT protects against Lipoprotein-X formation in a murine model of drug-induced intrahepatic cholestasis.
Amar MJA; Freeman LA; Nishida T; Sampson ML; Pryor M; Vaisman BL; Neufeld EB; Karathanasis SK; Remaley AT
Pharmacol Res Perspect; 2020 Feb; 8(1):e00554. PubMed ID: 31893124
[TBL] [Abstract][Full Text] [Related]
16. Immune-mediated acquired lecithin-cholesterol acyltransferase deficiency: A case report and literature review.
Ishibashi R; Takemoto M; Tsurutani Y; Kuroda M; Ogawa M; Wakabayashi H; Uesugi N; Nagata M; Imai N; Hattori A; Sakamoto K; Kitamoto T; Maezawa Y; Narita I; Hiroi S; Furuta A; Miida T; Yokote K
J Clin Lipidol; 2018; 12(4):888-897.e2. PubMed ID: 29937398
[TBL] [Abstract][Full Text] [Related]
17. LCAT- targeted therapies: Progress, failures and future.
Yang K; Wang J; Xiang H; Ding P; Wu T; Ji G
Biomed Pharmacother; 2022 Mar; 147():112677. PubMed ID: 35121343
[TBL] [Abstract][Full Text] [Related]
18. Possible induction of renal dysfunction in patients with lecithin:cholesterol acyltransferase deficiency by oxidized phosphatidylcholine in glomeruli.
Jimi S; Uesugi N; Saku K; Itabe H; Zhang B; Arakawa K; Takebayashi S
Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):794-801. PubMed ID: 10073988
[TBL] [Abstract][Full Text] [Related]
19. Transgenic overexpression of human lecithin: cholesterol acyltransferase (LCAT) in mice does not increase aortic cholesterol deposition.
Furbee JW; Parks JS
Atherosclerosis; 2002 Nov; 165(1):89-100. PubMed ID: 12208474
[TBL] [Abstract][Full Text] [Related]
20. The P274S Mutation of Lecithin-Cholesterol Acyltransferase (LCAT) and Its Clinical Manifestations in a Large Kindred.
Fountoulakis N; Lioudaki E; Lygerou D; Dermitzaki EK; Papakitsou I; Kounali V; Holleboom AG; Stratigis S; Belogianni C; Syngelaki P; Stratakis S; Evangeliou A; Gakiopoulou H; Kuivenhoven JA; Wevers R; Dafnis E; Stylianou K
Am J Kidney Dis; 2019 Oct; 74(4):510-522. PubMed ID: 31103331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
